| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |